BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 22308299)

  • 1. Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B).
    Reynolds MR; Magnuson EA; Wang K; Lei Y; Vilain K; Walczak J; Kodali SK; Lasala JM; O'Neill WW; Davidson CJ; Smith CR; Leon MB; Cohen DJ;
    Circulation; 2012 Mar; 125(9):1102-9. PubMed ID: 22308299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcatheter aortic valve replacement in nonsurgical candidates with severe, symptomatic aortic stenosis: a cost-effectiveness analysis.
    Simons CT; Cipriano LE; Shah RU; Garber AM; Owens DK; Hlatky MA
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):419-28. PubMed ID: 23838104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Risk.
    Baron SJ; Wang K; House JA; Magnuson EA; Reynolds MR; Makkar R; Herrmann HC; Kodali S; Thourani VH; Kapadia S; Svensson L; Mack MJ; Brown DL; Russo MJ; Smith CR; Webb J; Miller C; Leon MB; Cohen DJ
    Circulation; 2019 Feb; 139(7):877-888. PubMed ID: 30586747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A).
    Reynolds MR; Magnuson EA; Lei Y; Wang K; Vilain K; Li H; Walczak J; Pinto DS; Thourani VH; Svensson LG; Mack MJ; Miller DC; Satler LE; Bavaria J; Smith CR; Leon MB; Cohen DJ;
    J Am Coll Cardiol; 2012 Dec; 60(25):2683-92. PubMed ID: 23122802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs of periprocedural complications in patients treated with transcatheter aortic valve replacement: results from the Placement of Aortic Transcatheter Valve trial.
    Arnold SV; Lei Y; Reynolds MR; Magnuson EA; Suri RM; Tuzcu EM; Petersen JL; Douglas PS; Svensson LG; Gada H; Thourani VH; Kodali SK; Mack MJ; Leon MB; Cohen DJ;
    Circ Cardiovasc Interv; 2014 Dec; 7(6):829-36. PubMed ID: 25336467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness of Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis Versus Surgical Aortic Valve Replacement.
    Reynolds MR; Lei Y; Wang K; Chinnakondepalli K; Vilain KA; Magnuson EA; Galper BZ; Meduri CU; Arnold SV; Baron SJ; Reardon MJ; Adams DH; Popma JJ; Cohen DJ;
    J Am Coll Cardiol; 2016 Jan; 67(1):29-38. PubMed ID: 26764063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost effectiveness of transcatheter aortic valve replacement compared to medical management in inoperable patients with severe aortic stenosis: Canadian analysis based on the PARTNER Trial Cohort B findings.
    Hancock-Howard RL; Feindel CM; Rodes-Cabau J; Webb JG; Thompson AK; Banz K
    J Med Econ; 2013; 16(4):566-74. PubMed ID: 23356420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis.
    Reynolds MR; Magnuson EA; Lei Y; Leon MB; Smith CR; Svensson LG; Webb JG; Babaliaros VC; Bowers BS; Fearon WF; Herrmann HC; Kapadia S; Kodali SK; Makkar RR; Pichard AD; Cohen DJ;
    Circulation; 2011 Nov; 124(18):1964-72. PubMed ID: 21969017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: a Canadian perspective.
    Doble B; Blackhouse G; Goeree R; Xie F
    J Thorac Cardiovasc Surg; 2013 Jul; 146(1):52-60.e3. PubMed ID: 22795437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A).
    Elmariah S; Palacios IF; McAndrew T; Hueter I; Inglessis I; Baker JN; Kodali S; Leon MB; Svensson L; Pibarot P; Douglas PS; Fearon WF; Kirtane AJ; Maniar HS; Passeri JJ;
    Circ Cardiovasc Interv; 2013 Dec; 6(6):604-14. PubMed ID: 24221391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of preoperative moderate/severe mitral regurgitation on 2-year outcome after transcatheter and surgical aortic valve replacement: insight from the Placement of Aortic Transcatheter Valve (PARTNER) Trial Cohort A.
    Barbanti M; Webb JG; Hahn RT; Feldman T; Boone RH; Smith CR; Kodali S; Zajarias A; Thompson CR; Green P; Babaliaros V; Makkar RR; Szeto WY; Douglas PS; McAndrew T; Hueter I; Miller DC; Leon MB;
    Circulation; 2013 Dec; 128(25):2776-84. PubMed ID: 24152861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk.
    Fairbairn TA; Meads DM; Hulme C; Mather AN; Plein S; Blackman DJ; Greenwood JP
    Heart; 2013 Jul; 99(13):914-20. PubMed ID: 23696198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cost-utility analysis of transcatheter versus surgical aortic valve replacement for the treatment of aortic stenosis in the population with intermediate surgical risk.
    Tam DY; Hughes A; Fremes SE; Youn S; Hancock-Howard RL; Coyte PC; Wijeysundera HC
    J Thorac Cardiovasc Surg; 2018 May; 155(5):1978-1988.e1. PubMed ID: 29454487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis.
    Babaliaros V; Devireddy C; Lerakis S; Leonardi R; Iturra SA; Mavromatis K; Leshnower BG; Guyton RA; Kanitkar M; Keegan P; Simone A; Stewart JP; Ghasemzadeh N; Block P; Thourani VH
    JACC Cardiovasc Interv; 2014 Aug; 7(8):898-904. PubMed ID: 25086843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness of Self-Expandable Transcatheter Aortic Valves in Intermediate-Risk Patients.
    Tam DY; Hughes A; Wijeysundera HC; Fremes SE
    Ann Thorac Surg; 2018 Sep; 106(3):676-683. PubMed ID: 29730344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfemoral transcatheter aortic valve replacement compared with surgical replacement in patients with severe aortic stenosis and comparable risk: cost-utility and its determinants.
    Ribera A; Slof J; Andrea R; Falces C; Gutiérrez E; Del Valle-Fernández R; Morís-de la Tassa C; Mota P; Oteo JF; Cascant P; Altisent OA; Sureda C; Serra V; García-Del Blanco B; Tornos P; Garcia-Dorado D; Ferreira-González I
    Int J Cardiol; 2015 Mar; 182():321-8. PubMed ID: 25585368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes of inoperable patients with aortic stenosis randomly assigned to transcatheter aortic valve replacement or standard therapy.
    Kapadia SR; Tuzcu EM; Makkar RR; Svensson LG; Agarwal S; Kodali S; Fontana GP; Webb JG; Mack M; Thourani VH; Babaliaros VC; Herrmann HC; Szeto W; Pichard AD; Williams MR; Anderson WN; Akin JJ; Miller DC; Smith CR; Leon MB
    Circulation; 2014 Oct; 130(17):1483-92. PubMed ID: 25205802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry.
    Nazif TM; Dizon JM; Hahn RT; Xu K; Babaliaros V; Douglas PS; El-Chami MF; Herrmann HC; Mack M; Makkar RR; Miller DC; Pichard A; Tuzcu EM; Szeto WY; Webb JG; Moses JW; Smith CR; Williams MR; Leon MB; Kodali SK;
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):60-9. PubMed ID: 25616819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (placement of AoRTic TraNscathetER Valve).
    Dvir D; Waksman R; Barbash IM; Kodali SK; Svensson LG; Tuzcu EM; Xu K; Minha S; Alu MC; Szeto WY; Thourani VH; Makkar R; Kapadia S; Satler LF; Webb JG; Leon MB; Pichard AD
    J Am Coll Cardiol; 2014 Jan; 63(3):269-79. PubMed ID: 24140659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).
    Généreux P; Cohen DJ; Williams MR; Mack M; Kodali SK; Svensson LG; Kirtane AJ; Xu K; McAndrew TC; Makkar R; Smith CR; Leon MB
    J Am Coll Cardiol; 2014 Mar; 63(11):1100-9. PubMed ID: 24291283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.